Cancer Immunotherapy May Be Improved If Tregs Are Deftly Impaired – Genetic Engineering & Biotechnology News
|
Cancer Immunotherapy May Be Improved If Tregs Are Deftly Impaired
Genetic Engineering & Biotechnology News The balancing act that is cancer immunotherapy requires that the body's antitumor response be given a boost, but not too much of a boost. For example, simply getting rid of Tregs, the regulatory T cells that moderate the immune system's attack on … |
